מדיטבין 200 מ"ג

국가: 이스라엘

언어: 히브리어

출처: Ministry of Health

유효 성분:

GEMCITABINE AS HYDROCHLORIDE 200 MG/VIAL

제공처:

MEDISON PHARMA LTD

ATC 코드:

L01BC05

약제 형태:

POWDER FOR SOLUTION FOR INFUSION

관리 경로:

I.V

Manufactured by:

INTAS PHARMACEUTICALS LTD, INDIA

치료 그룹:

GEMCITABINE

치료 징후:

Palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-FU refractory pancreatic cancer. Gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. Breast cancer: Gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. Ovarian cancer: Gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

승인 날짜:

2012-11-01